How Nutrient Signaling Impacts Aging and Lifespan
Vorschaubild von YouTube. Abspielen lädt den YouTube-Player.
Verlauf & EmpfehlungenAus
Zuletzt angesehene Inhalte in diesem Browser behalten. Dein Verlauf bleibt auf diesem Gerät und wird nicht an Harbor gesendet. Abgespielte Videos können auch passende Videoempfehlungen sortieren.
Merkliste & Verlauf öffnen →Über dieses Video
Creator-Beschreibung · OriginaltextTextsprache: Englisch
A recent study titled "A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation, and shortened lifespan" investigates the effects of increased nutrient signaling through the mTORC1 pathway in mice. The researchers used genetically modified mice with active mutant variants of the RagC protein, which mildly increases nutrient signaling to mTORC1. These mice exhibited multiple signs of parenchymal damage, such as organ senescence, inflammation, and a reduced lifespan by approximately 30%. The study found that the parenchymal damage was caused by abnormal activation of myeloid cells, which led to further inflammatory damage. Therapeutically suppressing this inflammation in older mice extended their survival.
Practical Applications
1. Understanding Nutrient Signaling and Aging:
The mTORC1 pathway in cells is crucial for regulating growth in response to nutrients. When this pathway is mildly overactive, it can lead to damage in various organs, cause inflammation, and ultimately reduce lifespan. This means that even slight increases in nutrient intake, which overly stimulate this pathway, could accelerate aging and related health issues.
2. Reducing Inflammation:
The study shows that inflammation plays a key role in the aging process. By managing inflammation, it might be possible to reduce the damage caused by overactive nutrient signaling. This could involve lifestyle changes, dietary adjustments, or specific medications to control inflammation.
3. Potential Therapeutic Interventions:
For humans, this research suggests that targeting the mTORC1 pathway and inflammation could be beneficial in managing aging and increasing longevity. Drugs that inhibit mTORC1 signaling, like rapamycin, and anti-inflammatory supplements, like TMG (use code: POSHFITNESS for a discount), cistanche and curcumin, and other longevity and neuro-inflammation inhibitor drugs like naltrexone could potentially be used to slow down aging and mitigate age-related diseases.
For Naltrexone and Rapamycin go here:
https://healthspan.zenpatient.com/?via=peter#/get-started
#longevity #wellness #longevityscience #health #tmg
Reference
Ortega-Molina, A., Lebrero-Fernández, C., Sanz, A., Calvo-Rubio, M., Deleyto-Seldas, N., de Prado-Rivas, L., Plata-Gómez, A. B., Fernández-Florido, E., González-García, P., Vivas-García, Y., Sánchez García, E., Graña-Castro, O., Price, N. L., Aroca-Crevillén, A., Caleiras, E., Monleón, D., Borrás, C., Casanova-Acebes, M., de Cabo, R., & Efeyan, A. (2024). A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan. Nature Aging. https://pubmed.ncbi.nlm.nih.gov/38849535/
Peter Marino · 4 min · Quelle veröffentlicht: 2024-10-31
Zu Harbor hinzugefügt: 30.10.2026
Original auf YouTube ↗Automatisch eingeordnete Quelle. Creator-Aussagen sind keine unabhängige Evidenzprüfung und keine persönliche medizinische Beratung.